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Abstract
Background: Streptococcus pneumoniae is a major causative agent of severe infections, including sepsis, pneumonia,
meningitis, and otitis media, that has since become a major public health concern. In this study, the serotypes distribution
of pneumococcal isolates was investigated to predict the efficacy of the 7-valent pneumococcal conjugate vaccine (PCV7)
among the Malaysian populations.
Methodology/Principal Findings: A total of 151 clinical isolates were serotyped using multiplex PCR assays. Out of them,
there were 21.2% penicillin-resistant, 29.1% penicillin-intermediate, and 49.7% penicillin-susceptible S.pneumoniae strains.
Serotypes detected among the Malaysian isolates were 1, 3, 10A, 11A/11D, 12F/12A, 14, 15A, 15B/15C, 16F, 18C/18B/18A/
18F, 19A, 19F, 23F, 35B, 35F/47F, 6A/6B, 7C/7B/40, 7F/7A, 9V/9A, and 34. Serotype 19F and 23F were the two most prevalent
serotypes detected. Serotypes are highly associated with invasiveness of isolates (p=0.001) and penicillin susceptibility
(p,0.001). Serotype 19F was observed to have increased resistance against penicillin while serotype 19A has high invasive
tendency. Age of patients was an important factor underlying the pneumococcal serotypes (p=0.03) and clinical sites of
infections (p,0.001). High prevalence of pneumococcal isolates were detected among children ,5 years old at
nasopharyngeal sites while elderly adults $60 years old were at increased risk for pneumococcal bacteremia.
Conclusion/Significance: Current study revealed that a number of serotypes, especially those associated with high
penicillin resistance, have been formulated in the PCV7. Therefore, the protections expected from the routine use of PCV7
would be encouraging for the Malaysian. However, it is not possible to predict serotypes that might become predominant
in the future and hence continued surveillance of circulating serotypes will be needed.
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Introduction
Streptococcus pneumoniae is a major causative agent of the
morbidity and mortality among young children and adults [1].
More than one million children die of pneumococcal diseases
worldwide each year and the incidences are especially high in
developing countries. In contrast to the developed countries where
pneumococcal respiratory infections predominantly affected the
elderly group, death in children under 5 years of age in the
developing world are attributed to pneumococcal diseases. Among
them, children under 2 years old are typically the most severely
affected group.
An important contributing factor to the invasiveness and hence
the ability of the organism to cause diseases is the production of
polysaccharide capsule. Pneumococci are able to produce at least
90 immunologically distinct capsules that differ in their chemical
properties [2]. The capsule which present external to the cell wall
of pneumococcus disrupts the neutrophil-mediated and comple-
ment activity of bacterial cells leading to inhibition of opsonopha-
gocytosis [3]. This confers the organism with resistance against
phagocytosis and promotes bacterial evasion from the host
immune system [4]. Of the 90 capsular types, only a few are
causative agents of invasive diseases and associated with pediatric
diseases [5]. Serotypes 4 and 14 and serogroups 6, 7, 9, 18, 19, and
23 are known to be associated with pediatric diseases [5].
However, the association between serotypes/serogroups and
diseases incidences varied depending upon the geographical
distributions and time period of the investigations [5].
The prevalence and distributions of S.pneumoniae in Malaysia are
closely linked to neighboring countries within South East Asia
region and other countries in Asia [6]. In Malaysia, several
research groups have conducted investigations on the serotype
distributions in our population. This provides some clues though
still inadequate to give a comprehensive presentation of pneumo-
coccal diseases. A number of surveillance studies revealed that
pneumonia is the most common clinical presentation of pneumo-
coccal infection, with those children ,2 years of age accounted for
the most morbidity and mortality cases [7–9]. Other invasive
pneumococcal diseases (IPD) among local populations are
meningitis, septic arthritis, and bacteremia without focus (BWF)
[9]. Studies on serotypes distributions in Malaysia revealed
differing outcomes probably due to the lack of consistent and
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time interval between study, scale, and the geographical
dissemination of the study. A four years study conducted at a
major referral hospital in Kuala Lumpur identified the predom-
inant serotypes to be 6A, 6B, 14, and 19A [7]. In a separate study
by Rohani et al., they found serotypes 1, 2, 5, 6A, 8, 12A, 14, 19B,
20, and 23B were the most common serotypes implicated in IPD
[8]. However, whether these revealed a shift in serotypes
prevalence is unclear as the data could not be well correlated to
draw a definite conclusion.
Since the emergence of penicillin resistant strain in 1967,
antibiotic resistance strains of S. pneumoniae have spread worldwide.
The organism has also been reported to be resistant to other
antibiotics such as macrolides and quinolones [10–11]. Despite the
availability of multiple conventional antibiotics as well as the new
generation broad spectrum antibiotics with improved efficacy, the
management of pneumococcal infections has become difficult with
the rapid development of antimicrobial resistance in this organism.
Although the beta-lactam antibiotics, particularly penicillin still
remains as the main choice in antibiotic therapy against
pneumococcal diseases, the alarming rise of penicillin resistance
as well as others has prompted for the reconsideration of better
control and prevention strategies.
The majority of antibiotic resistance strains carry serotypes
which are not included in the currently in use conjugate vaccines
[12]. It has been reported that serotypes reported in both pediatric
and adult infections are frequently found among both drug
susceptible and resistant strains that colonize healthy children [13].
Therefore, the main focus of better management of pneumococcal
infection is currently through widespread usage of vaccination.
The available pneumococcal polysaccharide vaccine (PPV) covers
23 serotypes, which represents 90% of the strains responsible for
invasive diseases but are found to be not immunogenic in young
children. The alternative to this is the heptavalent pneumococcal
conjugate vaccine (PCV7) which is immunogenic in children ,2
years old. Apart from PCV7, PCV with additional formulations
depending on the manufacturers are also available. This includes
the 7-, 9-, 10-, and 13-valent PCV [14] that confer protection
against different number of pneumococcal serotypes.
All these clearly outlined the impact of pneumococcal diseases
to the populations especially for the young children. However, this
demanding information is still scarce despite the rising threats of
pneumococcal infections have been persisted among the Malay-
sian populations for many years. As carriages usually precede
pneumococcal diseases and the natures of invasiveness are
correlated to different pneumococcal serotypes, data on serotypes
distribution among local populations are needed. Hence, to
evaluate the coverage and the extent of potential protection
conferred by PCV7, the serotypes specific epidemiology distribu-
tions of pneumococcus from the University Malaya Medical
Centre (UMMC) was investigated.
Materials and Methods
Clinical isolates collection and culture conditions
A total of 151 pneumococcal isolates were obtained from
clinical samples processed stored at the Microbiology Laboratory
of the University of Malaya Medical Centre, Malaysia from March
1999 to February 2007 (except year 2001 and 2004). Control
strains of known serotypes (Quellung reaction) representing
different serotypes and serogroups were used in the study. The
serotypes included 1, 2, 3, 4, 5, 8, 13, 14, 20, 21, 31, 34, 37, 38, 39,
40, 44, 46, 6A, 7 A, 7B, 7C, 7F, 9A, 9N, 9L, 9L, 10A, 10F, 11 A,
11D, 11F, 12A, 12B, 12F, ISA, 15B, 15C, 15F, 16A, 16F, 17F,
33A, 35B, 35F, 35A, 35C, and 47F. The isolates were obtained
from invasive and non invasive sites of both pediatric and adult
patients. The source of the isolates included blood, cerebrospinal
fluid (CSF), nasopharyngeal (NP) secretion, tracheal secretion,
sputum, bronchoalveolar lavage (BAL), and others. Samples were
grown on 5% horse blood agar and incubated at 37uC in the
presence of 5% CO2 for 12–15 hours prior to other biochemical
and molecular assays.
Ethics Statement
The Ethical Committee of the University of Malaya Medical
Centre has exempted this study from review as these isolates were
from routine diagnosis and waived the need for consent due to the
fact that neither patient information nor identity was being used,
related, or involved in any aspect of the study.
Isolates identification
The isolates were identified as S. pneumoniae using conventional
microbiological methods including susceptibility to ethylhydrocu-
preine disc (optochin), catalase test and bile solubility.
Susceptibility testing
The antibiotic susceptibility of the strains was tested on Mueller
Hinton Agar (Oxoid) plates containing 5% sheep blood (Oxoid),
incubated at 37uC with 5% CO2 using the agar dilution method as
described [15]. The penicillin used was obtained from Sigma
Aldrich (Sigma Chemical Co., St. Louis, Mo). S. pneumoniae ATCC
49619 was used as control.
DNA extraction
Genomic DNA was extracted from the bacterial culture using a
previously described method [16]. Bacterial colonies suspended in
15 mlo fd H 2O were treated with 10 mg/ml Proteinase K and
0.lmM Tris HCL pH 7.5 and incubated at 37uC for another
10 minutes. Subsequently, the suspension was boiled for 5 minutes
and finally centrifuged at 13000 rpm for 2 minutes. The superna-
tant obtained was used as the template in the PCR reaction.
PCR amplification
The primers used in this study were extracted from previously
published sequences and the PCR protocol was as previously
described [17]. Briefly, the primers were grouped into seven
multiplex reactions as shown in Figure 1 and each reaction was
designed to include four primer pairs targeting four different
serotypes and another primer pair targeting the common region of
the cps operon as an internal positive control. The optimal PCR
condition for a 25 m1 reaction included 16 PCR buffer
(Fermentas, Lithuania), 2.5 mM MgCl2, 0.2 mM dNTP mix,
2 U Taq Polymerase (Fermentas) and primer pairs at varying
concentrations as shown in Table S1 [17]. The PCR cycling was
carried out in an Eppendorf Gradient Mastercycler with initial
denaturation step at 94uC for 4 minutes and the 30 amplification
cycles were performed with denaturation at 94uC for 45 s,
annealing temperature at 54uC for 45 s and extension temperature
at 65uC for 2 minutes and 30 s and finally completed with an
extension at 72uC for 2 minutes. The PCR product was
electrophoresed on a 2% TAB agarose gel for 1 hour at 70V
and the bands were analyzed using a UV transilluminator.
Statistical analysis
Association among serotypes, clinical sites of isolates, age
groups, and penicillin susceptibility were tested using Chi-square
test of independence or Fisher’s exact test, whenever appropriate.
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Minimal inhibitory concentrations
The isolates were categorized based on their susceptibility to
penicillin, termed as penicillin-susceptible S. pneumoniae (Sp),
penicillin-intermediate S. pneumoniae (Ip), and penicillin-resistant
S. pneumoniae (Rp). Penicillin-intermediate and -resistant strains
were collectively referred to as penicillin nonsusceptible strains. Of
the 151 isolates, there were 21.2% (32/151) Rp, 29.1% (44/151)
Ip, and 49.7% (75/151) Sp (Table 1). The prevalence of penicillin
susceptible to nonsusceptible strains was at near equal ratio
(penicillin susceptible 49.7% to penicillin nonsusceptible 50.3%).
Serotyping
Serotypes detected among the Malaysian isolates were 1, 3,
10A, 11A/11D, 12F/12A, 14, 15A, 15B/15C, 16F, 18C/18B/
18A/18F, 19A, 19F, 23F, 35B, 35F/47F, 6A/6B, 7C/7B/40, 7F/
7A, 9V/9A, and 34. Figure 2 shows a representative complete
seven multiplex reactions performed on 10 Rp strains. Serotype
19F was the most prevalent serotype (37.1%, 56/151) followed by
serotype 23F (10.6%, 16/151), serotype 1 (6.0%, 9/151) and
serotype 6A/6B (6.0%, 9/151) irrespective of their susceptibility to
penicillin. Together, serotype 19F and 23F accounted for almost
half of all cases (47.7%). As the largest serotype group, 78.6% (44/
56) of serotype 19F were nonsusceptible to penicillin (Table 1).
Out of them, 35.7% were penicillin-resistant. Besides this, a pool
of uncommon serotypes were detected including serotype 3, 10A,
12F/12A, 15A, 15B/15C, 16F, 18C/18B/18A/18F, 7C/7B/40,
and 7F/7A. Statistical analysis showed significant relationship
between serotype and penicillin susceptibility (p,0.001). In
particular, serotype 19F was the most significantly associated
group against penicillin resistance.
Majority of the clinical isolates were obtained from non invasive
sites (72.2%, 109/151). Among the non invasive sites, sputum
(27.8%, 42/109) and NP (25.2%, 38/109) constituted the two
main sites where pneumococcal isolates have been frequently
isolated (Table 2). Serotype 19F was determined to be the
dominant serotype in these two clinical sites (NP=40.0%,
sputum=32.0%). In addition, sputum, NP, and blood represent
the three major sites of pneumococcal isolations which accounted
for 77.5% (117/151) of all isolates. Other clinical sites included
tracheal secretion (7.9%), ear swab/pus (6.0%), pleural fluid
(2.0%), eye swab/pus (2.0%), cerebrospinal fluid 1.3%), bronch-
eoalveolar lavage (1.3%), and others (2.0%). Isolates from rare sites
such as Bartholin’s abscess and vaginal discharge were reported in
this study as well. Serotypes were associated with invasiveness of
the isolates (p=0.001) where serotype 19A was associated with
invasive sites (Table 3).
Statistical testing showed significant relationship between the age of
patients and serotypes (p=0.03) (Table 4). Patients aged 5–59 years
Figure 1. Sequential multiplex PCR approaches for pneumococcal capsular serotyping. Each of the seven reactions include five primer
pairs, four of which targets four different serotypes and another primer pair serves as internal positive control.
doi:10.1371/journal.pone.0019547.g001
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approximately half of all cases (47.0%, 71/151). High proportions
of serotype 19A (75.0%), 23F (75.0%), and 6A/6B (66.7%) were
isolated from patients within this age range. In addition, clinical sites
of pneumococcal isolations were highly associated with the age of
patients (p,0.001) (Table 2) whereby pneumococci were frequently
isolated from NP site of children ,5 years old. As high as 80.9% (38/
4 7 )o fp n e u m o c o c c a li s o l a t e si nc h i l d r e n,5 years of age were sourced
from non invasive sites particularly the NP sites (59.6%, 28/47). No
association was observed between age of patients and penicillin
susceptibility (p=0.551).
Discussion
The increase in reports of pneumococcal infections associated
with antibiotic resistant strains has prompted for better disease-
control and prevention strategies. The in-demand information on
local distribution of pneumococci is still very much insufficient. A
few studies conducted previously have reported different findings,
probably due to the study designs and different geographical
distributions (and hence the populations involved) in the studies
[7–9,18–21]. To promote surveillance and continue monitoring of
pneumococcal infections in Malaysia, this study was carried out to
investigate the distribution of serotype specific strains in relation to
various aspects of pneumococcal diseases and to evaluate the
efficacy of PCV7 among local community.
Although current study represents a single centre-based
investigation in Malaysia, the incidences of penicillin nonsuscep-
tible strains were remarkably high. Comparing study outcomes
reported by other researchers are not always feasible due to the
variations in study design. Moreover, the available epidemiological
data throughout the years is extremely scarce. To evaluate the
trend in penicillin resistance, studies reported by Rohani et al. [22]
and Nasir et al. [23] provided relatively good representation of
local epidemiological data covering patients of all age groups and
isolates from various clinical sites. Penicillin nonsusceptible strains
had increased substantially from 10.9% [22] to 31.0% [23] within
four years time and further increased to 50.3% based on current
study. Additionally, resistant strains has also increased from 5.5%
[22] to 20.0% [23] and slightly to 21.2% based on current study.
Our study clearly addresses the overwhelming penicillin resistance
among the local isolates of S.pneumoniae in recent years. Such
drastic increment especially the nonsusceptible strains could mean
further reduction in treatment outcomes for patients infected with
pneumococcal diseases.
Serotype 19F and 23F were the predominant serotypes among
local populations and this is in agreement with a previous study by
Cheong et al. [21]. In addition, the pool of serotypes has become
smaller towards higher penicillin resistance level. From the data,
serotype 19F, 23F, and 6A/6B were present persistently in all
three susceptibility groups and this suggests that tendency in
developing penicillin resistance might be serotype-specific. On the
Table 1. Pneumococcal serotypes distribution with respect to penicillin susceptibility.
Frequency (adjusted residual, % within serotype, % within susceptibility group)
Serotype
c Susceptible Intermediate Resistant Total
a
1 7 (1.7, 77.8, 9.3) 2 (20.5, 22.2, 4.5) 0 (21.6, 0.0, 0.0) 9 (6.0)
3 1 (1.0, 100.0, 1.3) 0 (0.6, 0.0, 0.0) 0 (20.5, 0.0, 0.0) 1 (0.7)
14 1 (21.3, 20.0, 1.3) 4 (2.5, 80.0, 9.1) 0 (21.2, 0.0, 0.0) 5 (3.3)
34 0 (21.4, 0.0, 0.0) 0 (20.9, 0.0, 0.0) 2 (2.7, 100.0, 6.3) 2 (1.3)
10A 1 (1.0, 100.0, 1.3) 0 (20.6, 0.0, 0.0) 0 (20.5, 0.0, 0.0) 1 (0.7)
11A/11D 1 (20.6, 33.3, 1.3) 2 (1.4, 66.7, 4.5) 0 (20.9, 0.0, 0.0) 3 (2.0)
12F/12A 3 (1.8, 100.0, 4.0) 0 (21.1, 0.0, 0.0) 0 (20.9, 0.0, 0.0) 3 (2.0)
15A 1 (1.0, 100.0, 1.3) 0 (20.6, 0.0, 0.0) 0 (20.5, 0.0, 0.0) 1 (0.7)
15B/15C 1 (1.0, 100.0, 1.3) 0 (20.6, 0.0, 0.0) 0 (20.5, 0.0, 0.0) 1 (0.7)
16F 2 (1.4, 100.0, 2.7) 0 (20.9, 0.0, 0.0) 0 (20.7, 0.0, 0.0) 2 (1.3)
18C 2 (1.4, 100.0, 2.7) 0 (20.9, 0.0, 0.0) 0 (20.7, 0.0, 0.0) 2 (1.3)
19A 7 (2.2, 87.5, 9.3) 1 (21.1, 12.5, 2.3) 0 (21.5, 0.0, 0.0) 8 (5.3)
19F 12 (25.3, 21.4, 16.0) 24 (2.8, 42.9, 54.5) 20 (3.4, 35.7, 62.5) 56 (37.1)
23F 9 (0.6, 56.3, 12.0) 1 (22.1, 6.3, 6.3) 6 (1.7, 37.5, 18.8) 16 (10.6)
35B 2 (0.0, 50.0, 2.7) 2 (0.9, 50.0, 4.5) 0 (21.1, 0.0, 0.0) 4 (2.6)
35F/47F 2 (0.6, 66.7, 2.7) 1 (0.2, 33.3, 2.3) 0 (20.9, 0.0, 0.0) 3 (2.0)
6A/6B 3 (21.0, 33.3, 4.0) 5 (1.8, 55.6, 11.4) 1 (20.8, 11.1, 3.1) 9 (6.0)
7C/7B/40 1 (1.0, 100.0, 1.3) 0 (20.6, 0.0, 0.0) 0 (20.5, 0.0, 0.0) 1 (0.7)
7F/7A 3 (1.8, 100.0, 4.0) 0 (21.1, 0.0, 0.0) 0 (20.9, 0.0, 0.0) 3 (2.0)
9V/9A 0 (21.0, 0.0, 0.0) 0 (20.6, 0.0, 0.0) 1 (1.9, 100.0, 3.1) 1 (0.7)
ND 16 (2.9, 80.0, 21.3) 2 (22.0, 10.0, 4.5) 2 (21.3, 10.0 6.3) 20 (13.2)
Total
b 75 (49.7) 44 (29.1) 32 (21.2) 151
aFrequency (total % within serotype).
bFrequency (total % within susceptibility groups).
cFisher’s exact test, p,0.001.
Abbreviation: ND, not-detected.
doi:10.1371/journal.pone.0019547.t001
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Ip but only in Rp group.
As age of patients is one of the important factors underlying
pneumococcal diseases, the relationship between age and
serotypes, clinical sites, and penicillin susceptibility were investi-
gated in this study. Respiratory tract remains as the most
important clinical site for pneumococcal infections where large
numbers of isolates were recovered from NP, sputum, and tracheal
secretions. Serotype 19F was essentially the most abundant
serotype particularly among younger age patients. Children ,5
Figure 2. Representative complete seven multiplex reactions performed on 10 Rp strains for serotyping. In each reaction, the strains
were arranged in the same position accordingly from left to right. The serotypes detected were: PR40(1), PR41(12F), PR44(19F), PR46(11A/D),
PR47(12F), PR48(1), PR49(23F), PR50(19F), PR55(not-detected), and PR56(23F) (annotations in parenthesis denotes the serotype; ND: not-detected).
Lane 1, 31, 61: 100 kb DNA ladder.
doi:10.1371/journal.pone.0019547.g002
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frequently infected with pneumococcal diseases. It was noted that
serotype 19A has a great potential in causing invasive pneumo-
coccal diseases.
To evaluate the efficacies of PCV7 among the Malaysian
population, serotypes covered under the vaccine were analyzed.
This PCV7 covers serotype 4, 6B, 9V, 14, 18C, 19F, and 23F and
also provides protection against those serotypes of the same
serogroup as the formulated types. It was determined that 87.5%
Rp (28/32), 79.5% Ip (35/44), and 45.3% Sp (34/75) are covered
by the current PCV7. This vaccine appears to be able to confer
protection against 64.2% of all incidences (97/151). Therefore,
effectiveness of PCV7 to our community would be encouraging.
Towards reducing the morbidity and mortality associated with
Table 2. Distribution of pneumococcal isolates based on age groups against the clinical sites of isolations.
Invasive Non invasive
Age
c Blood CSF Pleural fluid Sputum NP
Eye
swab/pus
Ear
swab/pus
Tracheal
secretion BAL Other
d Total
a
,5 7 1 1 2 28 0 5 2 1 0 47(31.1)
5–59 16 1 2 27 10 3 4 6 0 2 71(47.0)
$60 14 0 0 13 0 0 0 4 1 1 33(21.9)
Total
b 37(24.5) 2(1.3) 3(2.0) 42(27.8) 38(25.2) 3(2.0) 9(6.0) 12(7.9) 2(1.3) 3(2.0) 151
aFrequency (total % within age groups).
bFrequency (total % within clinical sites).
cFisher’s exact test, p,0.001.
dOther sites include left tonsil, Bartholin’s abscess, and vaginal discharge.
Abbrevations: CSF, cerebrospinal fluid; NP, nasopharyngeal; BAL, bronchoalveolar lavage.
doi:10.1371/journal.pone.0019547.t002
Table 3. Pneumococcal serotypes distribution with respect to invasiveness of isolates.
Frequency (adjusted residual, % within serotype, % within invasiveness)
Serotype
c Invasive Non invasive Total
a
1 3 (0.4, 33.3, 7.1) 6 (20.4, 66.7, 5.5) 9 (6.0)
30 ( 20.6, 0.0, 0.0) 1 (0.6, 100.0, 0.9) 1 (0.7)
14 3 (1.6, 60.0, 7.1) 2 (21.6, 40.0, 1.8) 5 (3.3)
34 0 (20.9, 0.0, 0.0) 2 (0.9, 100.0, 1.8) 2 (1.3)
10A 0 (20.6, 0.0, 0.0) 1 (0.6, 100.0, 0.9) 1 (0.7)
11A/11D 2 (1.5, 66.7, 4.8) 1 (21.5, 33.3, 0.9) 3 (2.0)
12F/12A 2 (1.5, 66.7, 4.8) 1 (21.5, 33.3, 0.9) 3 (2.0)
15A 0 (20.6, 0.0, 0.0) 1 (0.6, 100.0, 0.9) 1 (0.7)
15B/15C 1 (1.6, 100.0, 2.4) 0 (21.6, 0.0, 0.0) 1 (0.7)
16F 1 (0.7, 50.0, 2.4) 1 (20.7, 50.0, 0.9) 2 (1.3)
18C 0 (20.9, 0.0, 0.0) 2 (0.9, 100.0, 1.8) 2 (1.3)
19A 6 (3.1, 75.0, 14.3) 2 (23.1, 25,0, 1.8) 8 (5.3)
19F 6 (23.6, 10.7, 14.3) 50 (3.6, 89.3, 45.9) 56 (37.1)
23F 4 (20.3, 25.0, 9.5) 12 (0.3, 75.0, 11.0) 16 (10.6)
35B 1 (20.1, 25.0, 2.4) 3 (0.1, 75.0, 2.8) 4 (2.6)
35F/47F 1 (0.2, 33.3, 2.4) 2 (20.2, 66.7, 1.8) 3 (2.0)
6A/6B 1 (21.2, 11.1, 2.4) 8 (1.2, 88.9, 7.3) 9 (6.0)
7C/7B/40 1 (1.6, 100.0, 2.4) 0 (21.6, 0.0, 0.0) 1 (0.7)
7F/7A 1 (0.2, 33.3, 2.4) 2 (20.2, 66.7, 1.8) 3 (2.0)
9V/9A 1 (1.6, 100.0, 2.4) 0 (21.6, 0.0, 0.0) 1 (0.7)
ND 8 (1.3, 40.0, 19.0) 12 (21.3, 60.0, 11.0) 20 (13.2)
Total
b 42 (27.8) 109 (72.2) 151
aFrequency (total % within serotype).
bFrequency (total % within invasiveness).
cFisher’s exact test, p=0.001.
Abbreviation: ND, not-detected.
doi:10.1371/journal.pone.0019547.t003
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incorporated in the regular vaccination scheme for children in
Malaysia. This will help to reduce the incidence directly in those
young children as well as indirectly as a result of herd community
effect. Children with certain chronic diseases or preexisting medical
conditions which put them at high risk of developing IPD should be
considered for the vaccination. This includes sickle cell disease,
asplenia, immunosuppression, renal disease, cerebrospinal fluid
leaks,HIVinfection, andothers. Nonetheless,itis difficultto predict
the shift in serotype prevalence in the future. Thus, continuing
surveillance of pneumococcal carriage and diseases-related cases
will help to characterize the effectiveness of PCV7 and monitoring
ofdiseaseburdenduetonon-vaccineserotypesarecertainlyneeded.
This information will also provide the local regulatory body to
recommend suitable vaccines to be used.
It is particularly interesting as how these serotypes are related to
penicillin-resistance and the associated intracellular alterations that
lead to the changes against penicillin stress. Many other minor and
non-prevelant serotypes have also been detected among all three
groups. This may be due to variations in the geographical area,
disease and age groups of the patients. However, the high
prevalence of penicillin resistance in this study suggests the rapid
spread of resistant clones among pneumococci strains in this region.
Since pneumococci has the ability to switch serotypes by
horizontal transfer recombination and other genetic events, it is
important to monitor the frequency of the serotype exchanges in
order to predict long term efficacy of new vaccines. Therefore
continuous monitoring of antimicrobial resistance and serotype
distribution of S. pneumoniae is important for diseases management
and various disease-control policies among the Malaysian
population. The current study supports the need for a long term
surveillance program and also vaccination as measures for
prevention and control of pneumococcal infections. We hope that
current study will contribute to the regional body of knowledge on
S. pneumoniae serotypes distribution in Malaysia, such as the Asian
Strategic Alliance for Pneumococcal Diseases Prevention (ASAP)
in align to their mission on control and contain pneumococcal
diseases in Asian countries.
In conclusion, the rising threats of penicillin resistance among
the Malaysian pneumococcal isolates were clearly described in this
study. To our knowledge, such high incidences of penicillin
nonsusceptible S.pneumoniae among Malaysian populations is first
reported in this study. Due to the dominant role associated with
serotype 19F against various aspects of pneumococcal diseases,
reduced penicillin susceptibility among serotype 19F is of critical
concern. Aggravation might continue if no effective measures
regulating improper use of antibiotics is defined. These serotypes
as well as other minor vaccine and vaccine-related types have been
included in the 7-valent conjugate vaccine. Therefore, the efficacy
of this vaccine should be adequate in our population. However, it
is not possible to predict serotypes that might become predom-
inant in the future.
Table 4. Pneumococcal serotypes distribution with respect to age groups.
Frequency (adjusted residual, % within serotype, % within age group)
Serotype
c ,5 years 5–59 years $60 years Total
a
1 3 (0.1, 33.3, 6.4) 2 (21.5, 22.2, 2.8) 4 (1.7, 44.4, 12.1) 9 (6.0)
30 ( 20.7, 0.0, 0.0) 0 (20.9, 0.0, 0.0) 1 (1.9, 100.0, 3.0) 1 (0.7)
14 3 (1.4, 60.0, 6.4) 0 (22.1, 0.0, 0.0) 2 (1.0, 40.0, 6.1) 5 (3.3)
34 2 (2.1, 100.0, 4.3) 0 (21.3, 0.0, 0.0) 0 (20.8, 0.0, 0.0) 2 (1.3)
10A 0 (20.7, 0.0, 0.0) 1 (1.1, 100.0, 1.4) 0 (20.5, 0.0, 0.0) 1 (0.7)
11A/11D 0 (21.2, 0.0, 0.0) 2 (0.7, 66.7, 2.8) 1 (0.5, 33.3, 3.0) 3 (2.0)
12F/12A 1 (0.1, 33.3, 2.1) 0 (21.6, 0.0, 0.0) 2 (1.9, 66.7, 6.1) 3 (2.0)
15A 0 (20.7, 0.0, 0.0) 1 (1.1, 100.0, 1.4) 0 (20.5, 0.0, 0.0) 1 (0.7)
15B/15C 0 (20.7, 0.0, 0.0) 0 (20.9, 0.0, 0.0) 1 (1.9, 100.0, 3.0) 1 (0.7)
16F 0 (21.0, 0.0, 0.0) 1 (0.1, 50.0, 1.4) 1 (1.0, 50.0, 3.0) 2 (1.3)
18C 1 (0.6, 50.0, 2.1) 1 (0.1, 50.0, 1.4) 0 (20.8, 0.0, 0.0) 2 (1.3)
19A 1 (21.2, 12.5, 2.1) 6 (1.6, 75.0, 8.5) 1 (20.7, 12.5, 3.0) 8 (5.3)
19F 22 (1.7, 39.3, 46.8) 26 (20.1, 46.4, 36.6) 8 (21.7, 14.3, 24.2) 56 (37.1)
23F 3 (21.1, 18.8, 6.4) 12 (2.4, 75.0, 16.9) 1 (21.6, 6.3, 3.0) 16 (10.6)
35B 2 (0.8, 50.0, 4.3) 2 (0.1, 50.0, 2.8) 0 (21.1, 0.0, 0.0) 4 (2.6)
35F/47F 1 (0.1, 33.3, 2.1) 1 (20.5, 33.3, 1.4) 1 (0.5, 33.3, 3.0) 3 (2.0)
6A/6B 1 (21.3, 11.1, 2.1) 6 (1.2, 66.7, 8.5) 2 (0.0, 22.2, 6.1) 9 (6.0)
7C/7B/40 0 (20.7, 0.0, 0.0) 1 (1.1, 100.0, 1.4) 0 (20.5, 0.0, 0.0) 1 (0.7)
7F/7A 0 (21.2, 0.0, 0.0) 1 (20.5, 33.3, 1.4) 2 (1.9, 66.7, 6.1) 3 (2.0)
9V/9A 0 (20.7, 0.0, 0.0) 0 (20.9, 0.0, 0.0) 1 (1.9, 100.0, 3.0) 1 (0.7)
ND 7 (0.4, 35.0, 14.9) 8 (20.7, 40.0, 11.3) 5 (0.4, 25.0, 15.2) 20 (13.2)
Total
b 47 (31.1) 71 (47.0) 33 (21.9) 151
aFrequency (total % within serotype).
bFrequency (total % within age groups).
cFisher’s exact test, p=0.03.
Abbreviation: ND, not-detected.
doi:10.1371/journal.pone.0019547.t004
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